HISHOH Biopharma
Latest round
- Seed
Last raised
- Aug 2021
Total raised
- $2.3M
Investors
- 3
About HISHOH Biopharma
, Ltd. for sublingual immunotherapy for allergic diseases (allergen immunotherapy). The firm focuses on enhancing sublingual immunotherapy for allergic diseases. Their proprietary compounds are designed to work synergistically with existing therapies, aiming to improve efficacy through a new mechanism of action.
Who invested in HISHOH Biopharma
3 investors across 1 round
See all investors in HISHOH Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 4, 2021
Amount
$2.3M
Investors
Questions about HISHOH Biopharma
Who invested in HISHOH Biopharma?
HISHOH Biopharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HISHOH Biopharma raised?
HISHOH Biopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HISHOH Biopharma last raise money?
HISHOH Biopharma's most recent round on record is a Seed, in Aug 2021.
What does HISHOH Biopharma do?
HISHOH Biopharma is a pharmaceuticals company.
Where is HISHOH Biopharma headquartered?
HISHOH Biopharma is headquartered in Tokyo, Japan.
Which VCs invest in companies like HISHOH Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at HISHOH Biopharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like HISHOH Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.